CTI Life Sciences Fund

CTI Life Sciences Fund is a Montreal-based venture capital firm and company builder investing in emerging biotech and life sciences companies across Canada, the United States and Europe. Its investment approach is therapeutic- and modality-agnostic, spanning the life sciences broadly rather than concentrating on a single disease area or technology platform. The firm's stated remit is twofold: life sciences venture capital investment, and the conversion of promising scientific ideas and assets into investable, scalable and marketable biotech businesses.

Company building is the operational core of the strategy. CTI works alongside portfolio companies from early development through growth milestones, with hands-on support rather than passive capital provision. The firm combines long-term value creation with attention to potential exit opportunities, and describes portfolio management as purposeful and guided by industry relationships. Its team spans finance, pharmaceutical research and development, and company building.

The firm measures impact across three dimensions: investment results, treatments advanced for patients, and the growth of the life sciences ecosystem. Founding year, fund size, team size and typical check sizes are not disclosed.